Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07097701 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IR

StatusRecruiting
PhasePhase 3
SponsorLupin Ltd.
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jul 8, 2026 to Jan 22, 2027
    • Study completion date: Oct 4, 2026 to Feb 22, 2027
    • Start date changed from estimate of Oct 1, 2025 to Sep 3, 2025
    v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date: Sep 3, 2025 to Oct 1, 2025
    v4
  3. Start date: Jul 30, 2025 to Sep 3, 2025v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Lupin Ltd.
8 trials monitored
See 1 trial at risk
An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR compared to Mexiletine IR in Patients with Non-Dystrophic Myotonias (ACHILLES study)
Trial Details
NCT Number NCT07097701
Lead Sponsor Lupin Ltd.
Collaborators: Lupin Atlantis Holdings S.A.
Conditions
(from sponsor)		 Myotonia
Related terms Myotonia
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov